Phase 1 experience with BIIB021, an oral, synthetic, non-ansamycin Hsp90 inhibitor Meeting Abstract
| Authors: | von Hoff, D.; Beeram, M.; Brien, S. O.; Lamanna, N.; Castro, J.; Borad, M.; Burrows, F.; Trone, D.; Woodworth, J.; Tangri, S.; Perea, R.; Storgard, C.; Saif, M. W. |
| Abstract Title: | Phase 1 experience with BIIB021, an oral, synthetic, non-ansamycin Hsp90 inhibitor |
| Meeting Title: | AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics |
| Journal Title: | Molecular Cancer Therapeutics |
| Volume: | 6 |
| Issue: | 12 |
| Meeting Dates: | 2007 Oct 22-26 |
| Meeting Location: | Los Angeles, CA |
| ISSN: | 1535-7163 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2007-12-01 |
| Start Page: | 3375S |
| Language: | English |
| ACCESSION: | WOS:000251969000133 |
| PROVIDER: | wos |
| Notes: | --- - Meeting Abstract - Poster Presentation - Part 2 - "Source: Wos" |
MSK Authors
-
60Lamanna